NCT04468347View on ClinicalTrials.gov

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Interventions
DRUG

Flortaucipir F18

IV injection, 240 megabecquerel (MBq) (6.5 mCi)

PROCEDURE

Brain PET scan

positron emission tomography (PET) scan of the brain

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY